Safety and efficacy of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C in patients aged 65 years or older.

Foster, Graham R; Asselah, Tarik; Kopecky-Bromberg, Sarah; Lei, Yang; Asatryan, Armen; Trinh, Roger; Zadeikis, Neddie; Mensa, Federico J

Foster, Graham R; Asselah, Tarik; Kopecky-Bromberg, Sarah; Lei, Yang; Asatryan, Armen; Trinh, Roger; Zadeikis, Neddie; Mensa, Federico J.

Affiliation

Foster GR; Barts Liver Centre, Blizard Institute, Queen Mary University of London, London, United Kingdom.
Asselah T; Hepatology Department, UMR1149, Physiopathology and Treatment of Viral Hepatitis, Centre de Recherche sur l'Inflammation and Université Denis Diderot Paris 7, Beaujon Hospital, AP-HP, Clichy, France.
Kopecky-Bromberg S; AbbVie Inc., North Chicago, Illinois, United States of America.
Lei Y; AbbVie Inc., North Chicago, Illinois, United States of America.
Asatryan A; AbbVie Inc., North Chicago, Illinois, United States of America.
Trinh R; AbbVie Inc., North Chicago, Illinois, United States of America.
Zadeikis N; AbbVie Inc., North Chicago, Illinois, United States of America.
Mensa FJ; AbbVie Inc., North Chicago, Illinois, United States of America.

PLoS One ; 14(1): e0208506, 2019.

Article de En | MEDLINE | ID: mdl-30601818

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Quinoxalines / Sulfonamides / Benzimidazoles / Hépatite C chronique Type d'étude: Clinical_trials Limites: Aged / Female / Humans / Male Langue: En Journal: PLoS One Sujet du journal: CIENCIA / MEDICINA Année: 2019 Type de document: Article Pays d'affiliation: Royaume-Uni Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google